Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease

BACKGROUND: Bacterial infections are involved in more than a half of the exacerbations of chronic obstructive pulmonary disease (COPD). AIM: To evaluate the efficacy and safety of moxifloxacin in the outpatient treatment of moderate exacerbations of bacterial origin in the COPD patients. METHODS: We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Access Maced J Med Sci
Main Authors: Minov, Jordan, Stoleski, Sasho, Petrova, Tatjana, Vasilevska, Kristin, Mijakoski, Dragan, Bislimovska-Karadzhinska, Jovanka
Formato: Artigo
Idioma:Inglês
Publicado em: Republic of Macedonia 2018
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290446/
https://ncbi.nlm.nih.gov/pubmed/30559853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2018.445
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados